Department Pharmacology and Pharmacotherapy, Academic Medical Center, Amsterdam, the Netherlands.
Mol Cells. 2010 Feb 28;29(2):99-104. doi: 10.1007/s10059-010-0041-z. Epub 2010 Jan 29.
Regulatory processes including receptor phosphorylation and intracellular trafficking, also referred to as receptor internalization, are important processes to terminate G protein-coupled receptor (GPCR) signaling. Compelling evidence now indicates that internalization of a receptor is not necessarily the endpoint of signaling, but can also be the beginning of the activation of intracellular signaling pathways. Sphingosine-1-phosphate (S1P) receptors, which are activated by the endogenous phospholipid S1P, belong to the family of GPCRs. Interestingly, there is evidence indicating differential intracellular trafficking of one of the S1P receptor subtypes, the S1P1 receptor, upon agonist activation by either S1P or the synthetic agonist FTY720-P. Moreover, the differential effect of FTY720-P on S1P1 receptor regulation has been suggested to be the mechanism of action of this drug, which is now in Phase III clinical trials for the treatment of multiple sclerosis. It is thus of importance to get a good insight into the regulation of S1P receptors. This review therefore gives a detailed overview about the current state of knowledge on S1P receptor internalization and its functional implications, including some data on nuclear signaling of S1P receptors.
调控过程包括受体磷酸化和细胞内转运,也称为受体内化,是终止 G 蛋白偶联受体(GPCR)信号的重要过程。现在有令人信服的证据表明,受体的内化不一定是信号传递的终点,也可以是细胞内信号通路激活的起点。受体内源磷脂 S1P 激活的鞘氨醇-1-磷酸(S1P)受体属于 GPCR 家族。有趣的是,有证据表明,在 S1P 或合成激动剂 FTY720-P 激动剂激活后,一种 S1P 受体亚型 S1P1 受体的细胞内转运存在差异。此外,FTY720-P 对 S1P1 受体调节的差异影响被认为是该药物的作用机制,该药物目前正处于治疗多发性硬化症的 III 期临床试验阶段。因此,深入了解 S1P 受体的调节非常重要。因此,本综述详细概述了 S1P 受体内化及其功能意义的最新知识,包括一些关于 S1P 受体核信号的研究数据。